<?xml version="1.0" encoding="UTF-8"?><Media xmlns:cdr="cips.nci.nih.gov/cdr" BlockedFromVOL="Yes">
 
 <MediaTitle>Merkel - Immunohistochemical differential diagnosis</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>chart</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>Color</Color>
   <Labeled>Yes</Labeled>
   <ImageDimensions>
    
    
   <HeightPixels>534</HeightPixels><WidthPixels>2226</WidthPixels></ImageDimensions>
  </ImageData>
 </PhysicalMedia>
 
 <MediaSource>
  <OriginalSource>
   
   
   <SourceFilename>Immunohisto2.jpg</SourceFilename>
   <Comment>From: Busse et al., Case 19-2008: A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma. N. Eng. J. Med. 358:2717-2723, 2008, p.2719. Removed from caption  because of footnote in figure: Busse et al. Immunohistochemical Differential Diagnosis of Merkel Cell Carcinoma (Typical Staining Pattern). Copyright Â© 2008 Massachusetts Medical Society. All rights reserved.</Comment>
  </OriginalSource>
 </MediaSource><MediaContent>
  <Categories>
   <Category>treatment</Category>
  </Categories>
  
  <ContentDescriptions>
   <ContentDescription audience="Health_professionals" language="en">Immunohistochemical differential diagnosis of Merkel cell carcinoma (typical staining pattern: Eight-columned table depicting immunohistochemical studies useful in establishing a MCC diagnosis. Includes merkel-cell tumors, small cell carcinomas of the lung, small cell melanomas, and lymphomas;; also includes the positive or negative results of staining using   cytokertain 20, cytokeratin 7, neurofilaments, neuron-specific enolases, thyroid transcription factor 1, S100 proteins, and leukocyte common antigens. </ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Health_professionals" language="en">Figure 4. Merkel - Immunohistochemical differential diagnosis of Merkel-Cell Carcinoma (Typical Staining Pattern). </MediaCaption>
  </Captions>
 </MediaContent>
 <ProposedUse>
       <Summary cdr:ref="CDR0000062884">Merkel Cell Carcinoma Treatment</Summary>
       </ProposedUse>
 <ProcessingStatuses>
  <ProcessingStatus>
   <ProcessingStatusValue>Approved by expert reviewer</ProcessingStatusValue>
   <ProcessingStatusDate>2009-12-10</ProcessingStatusDate>
   <EnteredBy>2009-12-10</EnteredBy>
   
  </ProcessingStatus>
 </ProcessingStatuses>
</Media>
